JAMA Otolaryngology –Head & Neck Surgery : Prognostic Case Volume Thresholds in Patients With Head and Neck Squamous Cell Carcinoma
Interview with Benjamin L. Judson, MD, author of Prognostic Case Volume Thresholds in Patients With Head and Neck Squamous Cell Carcinoma (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - June 13, 2019 Category: General Medicine Source Type: podcasts
Subgroup analysis of phase 3 LUX-H&N1 trial: Afatinib versus methotrexate for head and neck squamous cell carcinoma
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Makoto Tahara, MD, PhD, from National Cancer Center Hospital East, Kashi...
Author: EMJ
Added: 02/20/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 20, 2016 Category: Cancer & Oncology Source Type: podcasts
Overview: Survival Outcomes with Concurrent Chemoradiation for Locally Advanced Elderly Head and Neck Cancer Patients Using the National Cancer Data Base
Approximately 45,000 new head and neck squamous cell carcinomas (HNSCC) are diagnosed
annually in the United States, with at least one-quarter occurring in patients >70 years of age.1,2
Tailoring...
Author: ASTROHN2016
Added: 02/19/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 19, 2016 Category: Cancer & Oncology Source Type: podcasts
LUX-H&N1: Phase 3 trial of afatinib versus methotrexate for head and neck squamous cell carcinoma
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Tanguy Seiwert, MD, from The University of Chicago Medicine, Chicago, IL...
Author: EMJ
Added: 02/01/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 1, 2016 Category: Cancer & Oncology Source Type: podcasts
